ClinicalTrials HQ

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

Recruiting · NCT06247826 · Registry updated 2026-04-29
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 InsertionNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingNot applicable2026-04-29NCT06247826

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Groupe Francais De Pneumo-Cancerologie7

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Hospitalier du MorvanBrestFrance3
CH Bretagne AtlantiqueVannesFrance7
CHU Hôpital NordSaint-EtienneFrance2
CHU La Réunion Site NordSaint-DenisFrance2
Hôpital Charles NicolleRouenFrance11
Hôpital CochinParisFrance56
Oncologie Institut CurieParisFrance2
Oncologie Polyclinique Bordeaux Nord AquitaineBordeauxFrance1
Oncologie Thoracique Hôpital NordMarseilleFrance2
Oncologie, Centre Antoine LacassagneNiceFrance1
Oncologie, CLCC DijonDijonFrance1
Pneumologie Centre HospitalierPauFrance3
Pneumologie Centre Hospitalier Intercommunal de CréteilCréteilFrance4
Pneumologie CHLe MansFrance2
Pneumologie CHI CornouailleQuimperFrance1
Pneumologie, CHU GrenobleGrenobleFrance1
Pneumologie, Hôpital Mutualiste ResamutVilleurbanneFrance1
Pneumologie, Hôpital TenonParisFrance1